Travere Therapeutics (TVTX) Misses Q1 EPS by 17c

Travere Therapeutics (NASDAQ: TVTX) reported Q1 EPS of ($0.40), $0.17 worse than the analyst estimate of ($0.23). Revenue for the quarter came in at $127.2 million versus the consensus estimate of $137.34 million.

For earnings history and earnings-related data on Travere Therapeutics (TVTX) click here.

You May Also Be Interested In

• Bessent: We Make A Market Buying Older Bonds
• ServiceTitan (TTAN) call put ratio 1.6 calls to 1 put into quarter results
• Qualcomm (QCOM) call put ratio 4.8 calls to 1 put with a focus on September 11 weekly calls as share price up 4%